1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Trial to Establish Non-inferiority of Immunogenicity of a Single-dose of CERVAVAC® Quadrivalent HPV Vaccine Compared to the Gardasil® Quadrivalent Vaccine Among Girls and Boys Aged 9 to 14 Years and in Girls/Women Aged 15 to 20 Years in ZambiaCervical Cancer Prevention; HPV Vaccination; Immunogenicity; Quadrivalent HPV Vaccine; Single Dose; Vaccine EffectivenessActive, not recruitingPhase 42026-10-05NCT07256912